Lion TCR Scores Triple FDA Win 2025, IND Cleared for HBV TCR Therapy
September 15, 2025 | 15:54
Fast Track and Orphan tags now backed by Phase one green light, feeding biotech investors hungry for TCR cell therapy FDA keyword intel.
Mobile Version